Abbott looks to acquire its way out of a growth slump
Where do you find growth in a low-growth economy? If Wall Street projections are correct, the about-to-close third quarter of 2016 will show a 2% year-over-year drop in earnings for the Standard & Poor’s 500 companies–the sixth consecutive quarterly...Buy Abbott Laboratories (ABT)
At current prices I think you’re getting two of Abbott Laboratories (ABT) most interesting growth opportunities at a deep discount. Abbott is a good mainstream pharmaceutical company. Abbott’s blockbuster drugs include Humira (for rheumatoid and psoriatic arthritis:...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!